200 related articles for article (PubMed ID: 31795352)
21. Construction of Ginsenoside Nanoparticles with pH/Reduction Dual Response for Enhancement of Their Cytotoxicity Toward HepG2 Cells.
Xu Y; Li X; Gong W; Huang HB; Zhu BW; Hu JN
J Agric Food Chem; 2020 Aug; 68(32):8545-8556. PubMed ID: 32686932
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2.
Yang F; Zhou J; Hu X; Yu SK; Liu C; Pan R; Chang Q; Liu X; Liao Y
Drug Deliv Transl Res; 2017 Oct; 7(5):731-737. PubMed ID: 28677033
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.
Yi H; Cho HJ; Cho SM; Lee DG; Abd El-Aty AM; Yoon SJ; Bae GW; Nho K; Kim B; Lee CH; Kim JS; Bartlett MG; Shin HC
BMC Cancer; 2010 May; 10():211. PubMed ID: 20482808
[TBL] [Abstract][Full Text] [Related]
24. Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer.
Lev-Ari S; Starr AN; Vexler A; Kalich-Philosoph L; Yoo HS; Kwon KR; Yadgar M; Bondar E; Bar-Shai A; Volovitz I; Schwarz Y
Food Funct; 2021 Sep; 12(17):8068-8077. PubMed ID: 34286798
[TBL] [Abstract][Full Text] [Related]
25. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
26. Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy.
Jin X; Yang Q; Cai N
Int J Nanomedicine; 2018; 13():3827-3838. PubMed ID: 30013338
[TBL] [Abstract][Full Text] [Related]
27. Sulfated derivatives of 20(S)-ginsenoside Rh2 and their inhibitory effects on LPS-induced inflammatory cytokines and mediators.
Fu BD; Bi WY; He CL; Zhu W; Shen HQ; Yi PF; Wang L; Wang DC; Wei XB
Fitoterapia; 2013 Jan; 84():303-7. PubMed ID: 23266729
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
29. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Liu X; Sun Y; Yue L; Li S; Qi X; Zhao H; Yang Y; Zhang C; Yu H
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706758
[TBL] [Abstract][Full Text] [Related]
30. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells.
Yi PF; Bi WY; Shen HQ; Wei Q; Zhang LY; Dong HB; Bai HL; Zhang C; Song Z; Qin QQ; Lv S; Wu SC; Fu BD; Wei XB
Eur J Pharmacol; 2013 Jul; 712(1-3):60-6. PubMed ID: 23665488
[TBL] [Abstract][Full Text] [Related]
32. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions.
Wang L; Liu Y; Zhao J; Li C; Zhou Y; Du J; Wang Y
Colloids Surf B Biointerfaces; 2017 Dec; 160():462-472. PubMed ID: 28988124
[TBL] [Abstract][Full Text] [Related]
34. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2.
Kim YS; Kim DS; Kim SI
Int J Biochem Cell Biol; 1998 Mar; 30(3):327-38. PubMed ID: 9611775
[TBL] [Abstract][Full Text] [Related]
36. Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from
Wang DD; Kim YJ; Baek NI; Mathiyalagan R; Wang C; Jin Y; Xu XY; Yang DC
J Ginseng Res; 2021 Jan; 45(1):48-57. PubMed ID: 33437156
[TBL] [Abstract][Full Text] [Related]
37. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
[TBL] [Abstract][Full Text] [Related]
38. Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1.
Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
Anticancer Agents Med Chem; 2020; 20(4):495-503. PubMed ID: 31814556
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
Bi X; Xia X; Mou T; Jiang B; Fan D; Wang P; Liu Y; Hou Y; Zhao Y
Eur J Pharmacol; 2014 Nov; 742():145-52. PubMed ID: 25199964
[TBL] [Abstract][Full Text] [Related]
40. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
